Brokerages Set Ardent Health, Inc. (NYSE:ARDT) Target Price at $14.58

Ardent Health, Inc. (NYSE:ARDT) has been assigned an average rating of “Hold” from the twelve analysts that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $14.5833.

A number of equities research analysts have commented on ARDT shares. Royal Bank Of Canada cut their target price on shares of Ardent Health from $21.00 to $16.00 and set an “outperform” rating for the company in a research report on Friday, November 14th. Bank of America lowered their target price on Ardent Health from $12.00 to $10.00 and set an “underperform” rating on the stock in a research report on Thursday, November 13th. Morgan Stanley reiterated an “equal weight” rating and set a $12.00 price objective (down from $22.00) on shares of Ardent Health in a research note on Friday, November 14th. UBS Group decreased their target price on shares of Ardent Health from $14.50 to $14.00 and set a “buy” rating on the stock in a research note on Thursday, December 18th. Finally, Truist Financial lowered their price target on shares of Ardent Health from $21.00 to $13.00 and set a “buy” rating on the stock in a report on Friday, November 14th.

Ardent Health Price Performance

Shares of NYSE ARDT opened at $9.58 on Friday. The firm has a market cap of $1.37 billion, a P/E ratio of 6.60, a PEG ratio of 5.66 and a beta of 0.72. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. Ardent Health has a twelve month low of $8.07 and a twelve month high of $15.59. The company has a 50 day moving average of $8.88 and a 200 day moving average of $11.18.

Trending Headlines about Ardent Health

Here are the key news stories impacting Ardent Health this week:

• Neutral Sentiment: Multiple law firms are soliciting lead‑plaintiff applicants and reminding investors of a March 9, 2026 deadline to join pending class actions; these notices increase legal activity but are procedural rather than new allegations. Schall Law Firm Notice
• Negative Sentiment: At least one class action has been filed alleging securities fraud tied to a steep stock drop after Ardent’s disclosures about collectability and reserves; plaintiffs allege misleading statements by company executives. BFA Law – Class Action Filed
• Negative Sentiment: Hagens Berman and other firms are publicly investigating Ardent over an alleged ~$97M accounting “shock” tied to a rigid 180‑day cliff approach to reserves for uncollectible accounts — a practice said to contradict prior disclosures about using detailed historical collection reviews. That raises risk of restatements, regulatory scrutiny, or additional litigation. Hagens Berman Investigation
• Negative Sentiment: Multiple national plaintiff firms (Pomerantz, Robbins Geller, Levi & Korsinsky, Faruqi & Faruqi, Rosen, Gross, Glancy, etc.) have filed or announced actions and client solicitations around the same class period; crowded litigation can increase settlement pressure and legal costs. Example: Schall/Multiple Notices

Institutional Investors Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently bought and sold shares of ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Ardent Health by 103.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after acquiring an additional 7,182 shares during the period. Goldman Sachs Group Inc. grew its holdings in Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after buying an additional 724,841 shares in the last quarter. Jane Street Group LLC increased its stake in Ardent Health by 235.1% in the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock worth $790,000 after acquiring an additional 40,318 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Ardent Health by 574.9% during the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock worth $550,000 after acquiring an additional 34,276 shares in the last quarter. Finally, CWM LLC boosted its position in shares of Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company’s stock valued at $30,000 after acquiring an additional 2,001 shares during the last quarter.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.